Nikhil Aggarwal, Founder & CEO, Grip Invest, says that high-quality corporate bonds can offer returns 300–450 basis points ...

BeOne Medicines’ sonrotoclax receives US FDA approval as first and only BCL2 inhibitor for R/R mantle cell lymphoma: San Carlos, California Saturday, May 16, 2026, 14:00 Hrs [IS ...

CISCE announced ICSE and ISC results with near-perfect pass rates: 99.78% for Class 10 and 99.66% for Class 12 in NCR, with girls outperforming boys.

The Registrar of Companies found that the company remained without a whole-time Company Secretary from 2014 to 2020 in ...

FDA accelerated approval covers relapsed/refractory MCL after ≥2 lines including a BTK inhibitor, positioning sonrotoclax as ...

Palo Alto Networks is acquiring Portkey, doubling the AI infrastructure startup's valuation. This and more in today's ETtech ...

For Management and Public Policy, valid IPMAT 2026 score. IIT Mandi invites applications for its five-year integrated MBA ...

Kyntra Bio, Inc. (NASDAQ: KYNB) Q1 2026 Earnings Call Transcript May 11, 2026 Kyntra Bio, Inc. misses on earnings expectations. Reported EPS is $-3.76 EPS, expectations were $-3.36.

Preview ASCO 2026 late-breaking cancer trials—from TNBC ADC survival gains to lung, liver, prostate and myeloma readouts ...

Smartphones, mobile trading apps, and digital onboarding have made market access easier than ever. Stock Market News: A quiet shift is underway in India's stock markets. Nearly one in four investors ...

Good afternoon, and welcome to RingCentral's First Quarter 2026 Conference Call. Joining me today are Vlad Shmunis, Founder, Chairman and ...

Good afternoon, everyone, and thank you for joining us today to discuss Kyntra Bio, Inc.’s first quarter 2026 financial and business results. I am Gaia Vasiliver-Shamis from LifeSci Advisors. Joining ...